The largest database of trusted experimental protocols

62 protocols using ifn β

1

Investigating PD-L1 Induction in Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDMs were generated using Mkp-1+/+ and Mkp-1−/− mice on a C57BL/6J background as previously described (27 (link)). BMDMs were treated with LPS (O55:B5) (Calbiochem) or heat-killed E. coli for different times to assess protein or mRNA levels. To assess the roles of IFNAR1, JAK1/2, and TYK2 in PD-L1 induction, BMDMs were pretreated with 10 μg/ml of IFNAR1-neutralizing or isotype control mAb overnight, or with a pharmacological inhibitor of either JAK1/2 (Ruxolitinib) or TYK2 (Deucravacitinib) for 30 min, and then stimulated with E. coli for 24 h. To assess the effect of type I IFN on PD-L1 expression in BMDM, Mkp-1+/+ and Mkp-1−/− BMDMs were treated with 20 ng/ml IFN-β (BioLegend) for different times or with escalating doses of IFN-β for 16 h.
+ Open protocol
+ Expand
2

Zbtb20 Expression in Cultured Splenic B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
AutoMACS-isolated splenic B cells from naïve mice were cultured in the presence of IL-1β (5 ng/mL; BioLegend), IL-6 (40 ng/mL; BioLegend) IL-9 (12.5 ng/mL; BioLegend), IL-12 (5 ng/mL; R&D Systems), IL-33 (40 ng/mL; Peprotech), IFN-α (1000 U/mL; BioLegend), IFN-β (500 U/mL; BioLegend), or IFN-γ (200 ng/mL; BioLegend) with lipopolysaccharide (LPS; 10 ng/mL) for 24 h at 37 °C. Cells were subjected to Zbtb20 intracellular staining or lysed for qRT-PCR assays.
+ Open protocol
+ Expand
3

Cytokine Profiling of Virus-Infected Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were infected in 6-, 12-, and 24-well plates. Post-infection cell culture supernatants were collected from infected cells and stored at -70°C. Paired antibodies and recombinant mouse IL-1β, TNF-α, IL-6, IL-10 (eBioscience), and IFN-β (BioLegend) were used as standards to determine cytokine concentrations according to the manufacturers’ instructions.
+ Open protocol
+ Expand
4

Characterizing SARS-CoV-2 Immune Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
IFN-β and IFN-λ1 were purchased from BioLegend. SeV was purchased from Charles River, and Poly(I:C) was purchased from Invivogen. Ruxolitinib was purchased from Selleck Chemicals. The following antibodies were used for Western blotting or immunofluorescence: anti-RIG-I (Cell Signaling Technology, 3743S), anti-MDA-5 (Cell Signaling Technology, 5321S), anti-MAVS (Cell Signaling Technology, 3993S), anti-IRF3 (Cell Signaling Technology, 11904S), anti-Phospho-IRF3 (Ser396) (Cell Signaling Technology, 4947S), STAT1 (Cell Signaling Technology, 14994), p-STAT1 (Cell Signaling Technology, 9167), anti-SARS-CoV-2 nucleocapsid (GeneTex, GTX135357), anti-SARS-CoV-2 ORF6 (Novus Biologicals, NBP3-05707), anti-SARS-CoV-2 Spike (Absolute Antibody, CR3022), and anti-Tubulin (Sigma, T6199). HRP-conjugated secondary antibodies (anti-mouse or anti-rabbit) were purchased from Amersham. Alexa Fluor fluorescent secondary antibodies were purchased from Invitrogen.
+ Open protocol
+ Expand
5

Multimodal Dissection and Analysis of Immune Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
LN, spleen, liver and epidydimal VAT were harvested 18 h after pDC transfer. LNs were smashed through a nylon net (pore size 70 μm). Spleen was digested with collagenase D (1 mg/ml) and DNase 1 (1 mg/ml) for 20 min at 37°C in RPMI 1640 media. Subsequently, the tissue was smashed through a nylon net and red blood cell lysis (Pharmlysis, BD) was performed before FACS staining. Liver was smashed through a nylon net by scraping it with a lid of the petri dish with PBS and 2 mM EDTA. The cell suspension was placed on a Lymphoprep® gradient (STEMCELL technologies) and centrifuged at 800 g without break for 20 min at RT. Cells were harvested form the interphase, washed with PBS and stained with antibodies for flow cytometry. VAT tissue was minced with a scalpel and digested with Collagenase 2 (1 mg/ml in RPMI 1640 media) for 25 min at 37°C under continuous rotation. The suspension was centrifuged and the cell pellet (stromal-vascular fraction) was taken up in red blood cell lysis buffer before staining for flow cytometry.
For the ELISA of IFN-α (PBL, InterferonSource) and IFN-β (Biolegend) one fat pad of epidydimal VAT was lysed in T-PER™ Tissue Protein Extraction Reagent (ThermoFisher) with protease inhibitor (Roche). Amount of cytokine was calculated per one total fat pad.
+ Open protocol
+ Expand
6

Cytokine Profiling of IFN-β Deficient BMDMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
IFN-β−/− BMDMs were infected as described previously and treated with 50 pg/mL IFN-β. An additional 50 pg/mL of IFN-β was added at 3 hpi, and cell culture supernatants were collected at 6 hpi. Concentrations of selected cytokines were determined using a custom ProcartaPlex magnetic bead-based multiplex assay (Thermo Fisher Scientific) on the Luminex MAGPIX® platform according to manufacturer’s instructions. IFN-α (PBL Assay Science), IFN-β (BioLegend), CCL12 (R&D Systems) and CCL3 (R&D Systems) protein levels were measured using ELISAs.
+ Open protocol
+ Expand
7

Cytokine profiling in lung homogenates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lung homogenates were centrifuged, and the supernatants were collected. Filtered cell-free lung homogenates were used to detect IL-1α, IGF-1, IL-13, CCL3, CCL5, CXCL1, CXCL2 (R&D Systems), IL-2, TGF-β, IL-4, IL-5, IL-6, IL-12p40, IFN-γ, CCL2 (B&D Biosciences), IL-10, IL-17, IFN-β, TNF and GM-CSF (Biolegend) by enzyme-linked immunosorbent assay (ELISA).
+ Open protocol
+ Expand
8

Cytokine and Chemokine Profiling in Murine Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytokines and chemokines were measured from sera, spleen, and liver taken from uninfected control mice as well as from infected mice on days 1 and 3 post-infection. Spleen and liver homogenates were centrifuged at 15,000 g for 15 min, and the supernatants were used for cytokine and chemokine analyses. The following ELISA kits were used: G-CSF (R&D Systems), IL-6, IFN-γ, and IL-12p70 (Invitrogen), MCP-1 and IFN-β (Biolegend). Data are expressed as mean pg/ml ± SEM.
+ Open protocol
+ Expand
9

Quantification of Cytokine Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Levels of cytokines from colon and sera samples were measured by ELISA according to the manufacturers’ instructions (IL-18 from eBioscience, IFN-β from BioLegend and all other cytokines from Millipore).
+ Open protocol
+ Expand
10

Murine and Human B Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For mice, splenic B cells were purified from WT, Ifnar−/−, Tbx21−/−, and Ifngr−/− mice by CD43 microbead depletion (Miltenyi Biotec). Purified B cells were cultured in RPMI at 37°C for 48 h at 106 cells/well in a 96-well plate with or without 5 ng/ml R848, 1 µg/ml anti–mouse IgM F(ab')2 fragment (Jackson ImmunoResearch Laboratories, Inc.), 1 µg/ml anti–mouse CD40 (SouthernBiotech), recombinant mouse IFN-γ or IFN-β (200 and 300 U/ml, respectively; BioLegend), and 500 nM ruxolitinib or 500 nM tofacitinib. For co-culture experiments, congenically marked CD45.1 WT and CD45.2 Ifngr−/− B cells were stimulated together in 96-well plates (106 total cells/well). B cell surface marker and transcription factor expression was evaluated by flow cytometry. Cell proliferation was evaluated by Cell Trace violet (Invitrogen) dilution.
Total human B cells were purified by the Human B Cell Isolation kit II (Miltenyi Biotec). Total B cells were plated at 5 × 104 in a 96-well plate for 24 or 72 h with 10 µg/ml anti-IgM (Jackson ImmunoResearch Laboratories, Inc.), 5 µg/ml CD40L (PeproTech), or 3.75 µg/ml R848 (InvivoGen) with or without 10 µg/ml IFN-γ (R&D Systems). For JAK inhibitor experiments, ruxolitinib or tofacitinib was added at 100 nm or 500 nm at the initiation of culture. Cells were analyzed at 24- and 72-h time points.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!